Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/71520
標題: Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls
作者: Chen, D.R.
Chen, S.T.
Wang, T.W.
Tsai, C.H.
Wei, H.H.
Chen, G.J.
Yang, T.C.
Lin, C.
Lin, P.H.
期刊/報告no:: Toxicology Letters, Volume 202, Issue 3, Page(s) 244-252.
摘要: Both 17 beta-estradiol-2,3-quinone (E(2)-2,3-Q) and 17 beta-estradiol-3,4-quinone (E(2)-3,4-Q) are reactive metabolites of estrogen that are thought to be responsible for the estrogen-induced genotoxicity. The aim of this study was to establish a methodology to analyze estrogen quinone-derived protein adducts and to measure the background levels of these adducts in human serum albumin (Alb) derived from female blood donors in Taiwan. Results from in vitro experiments confirmed that the production of estrogen quinone-derived adducts on serum Alb increased with increased concentration of estrogen quinones. Time-course experiments suggested that both E(2)-2,3-Q- and E(2)-3,4-Q-derived adducts rapidly reached maximum values at 10 min mark and remained constant thereafter for up to 24 h. Additionally, with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) pretreatment, the production of estrogen quinone-derived protein adducts was detected in human MCF-7 breast cancer cells exposed to estrogen. Co-treatment of a catechol-O-methyl transferase inhibitor further enhanced the production of estrogen quinone-derived adducts in all cases. When we investigated the levels of estrogen quinone-derived adducts in human serum Alb, cysteinyl adducts of E(2)-2,3-Q-1-S-Alb, E(2)-2,3-Q-4-S-Alb, and E(2)-3,4-Q-2-S-Alb were detected in all healthy female controls (n = 10) with median levels at 147 (range 14.1-533), 197 (range 30.0-777), and 65.6 (range 17.6-1360) (pmol/g), respectively. We noticed that levels of E(2)-2,3-Q-derived adducts were 2-fold greater than those of E(2)-3,4-Q-2-S-Alb in controls whereas levels of E(2)-3,4-Q-2-S-Alb were 2-fold higher than those of E(2)-2,3-Q-derived adducts in patients (n = 20). Additionally, levels of E(2)-2,3-Q-4-S-Alb correlated significantly with those of E(2)-3,4-Q-2-S-Alb (correlation coefficient r = 0.684-0.850, p < 0.05). Overall, we conclude that cumulative body burden of E(2)-3,4-Q is a significant predictor of breast cancer. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
URI: http://hdl.handle.net/11455/71520
ISSN: 0378-4274
文章連結: http://dx.doi.org/10.1016/j.toxlet.2011.02.010
Appears in Collections:期刊論文

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.